Avalon Global Asset Management’s Eli Lilly LLY Stock Holding History

Avalon Global Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$8.26M	–	48
2025 Q1	$8.26M	Hold	10,000	–	–	1.16%	26
2024 Q4	$7.72M	Hold	10,000	–	–	1.85%	22
2024 Q3	$8.86M	Hold	10,000	–	–	1.33%	25
2024 Q2	$9.05M	Hold	10,000	–	–	2.06%	22
2024 Q1	$7.78M	Hold	10,000	–	–	1.12%	27
2023 Q4	$5.83M	Hold	10,000	–	–	2.05%	22
2023 Q3	$5.37M	Hold	10,000	–	–	2.1%	21
2023 Q2	$4.69M	Buy	+10,000	New	+$4.19M	1.73%	22

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Avalon Global Asset Management's LLY Position: Q2 2025 in Review

Avalon Global Asset Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 10,000 shares — an estimated $8.26M sold.

Avalon Global Asset Management first reported a position in LLY in Q2 2023 and held it in 8 quarters. The position peaked at $9.05M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

Avalon Global Asset Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
Avalon Global Asset Management sold 10,000 Eli Lilly shares in Q2 2025, an estimated $8.26M.
Avalon Global Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 8 quarters.
Avalon Global Asset Management's Eli Lilly position peaked at $9.05M in Q2 2024.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Avalon Global Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.